Moderate-quality evidence suggests that scalp cooling is an effective measure for preventing alopecia induced by chemotherapy agents in solid tumor treatment and reduces the need for wearing wigs in these patients. No studies comparing automated versus manual scalp cooling methods have been found.
Some private and public health sponsors from high-income countries consulted over scalp cooling in patients with solid tumours under chemotherapy, at risk of alopecia, without specifying any of the methods currently available.
Some of the Clinical Practice Guidelines consulted on treatment of women with breast cancer and chemotherapy administration recommend scalp cooling as prevention for chemotherapy-induced alopecia.
No economic evaluations published in Argentina have been found, therefore the cost-effectiveness and budgetary impact of this technology is unknown.
